Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | -0.91% |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 284.27% |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | -130.72% |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | -15.92% |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -108.14% |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 38.02% |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 13.47% |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | -480.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -480.58% |
| Mar 31, 2026 | -356.68% |
| Dec 31, 2025 | 29.55% |
| Sep 30, 2025 | -19.13% |
| Jun 30, 2025 | 37.08% |
| Mar 31, 2025 | 160.61% |
| Dec 31, 2024 | 69.31% |
| Sep 30, 2024 | -46.87% |
| Jun 30, 2024 | -231.84% |
| Mar 31, 2024 | -1,242.62% |
| Dec 31, 2023 | -160.95% |
| Sep 30, 2023 | -154.74% |
| Jun 30, 2023 | 163.76% |
| Mar 31, 2023 | 112.37% |
| Dec 31, 2022 | 35.19% |
| Sep 30, 2022 | 59.97% |
| Jun 30, 2022 | -214.73% |
| Mar 31, 2022 | -1,105.92% |
| Dec 31, 2021 | -331.62% |
| Sep 30, 2021 | -122.06% |